Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.

Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?

Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?

Trypanosoma brucei prenylated-protein carboxyl methyltransferase prefers farnesylated substrates

Pages

Subscribe to Makerere University College Of Health Sciences | MakCHS RSS